News
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
TCS Group Holding PLC: notification of 5-year performance linked share warrants to Mr. Pavel Fedorov
TCS Group Holding PLC: notification of 5-year performance linked share warrants to Mr. Pavel Fedorov
DGAP-News: Cryptology's estimated NAV per share as of 29/12/2021 is €10.03 as Hauck & Aufhäuser updates Cryptology 'Buy' Rating to €13.00
DGAP-News: Cryptology's estimated NAV per share as of 29/12/2021 is €10.03 as Hauck & Aufhäuser updates Cryptology 'Buy' Rating to €13.00
Turkiye Garanti Bankasi A.S.: Coupon Rate of Bank Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon Rate of Bank Bonds to Qualified Investors
Photon Energy Group Leads Series A Equity Round in Lerta
Photon Energy Group Leads Series A Equity Round in Lerta
NCSP Group's consolidated cargo turnover for 11M 2021 increased by 3.8%
NCSP Group's consolidated cargo turnover for 11M 2021 increased by 3.8%
EQS-Adhoc: Polyphor closes merger with EnBiotix and is renamed Spexis
EQS-Adhoc: Polyphor closes merger with EnBiotix and is renamed Spexis
EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Adhoc: Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
EQS-Adhoc: Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
Sistema PJSFC: Sistema reports acquisition of shares under buyback programme
Sistema PJSFC: Sistema reports acquisition of shares under buyback programme
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)